Trametinib-Associated Bradycardia

Journal article

Peer reviewed

Luai Alhazmi, Mohammad M Karim, Mohammad Al-Sarie, Roland Skeel and Saima Karim

American journal of therapeutics, Vol.26(5), pp.e657-e659

09/2019

PMID: 31241492

Abstract

Administration, Oral

Antineoplastic Combined Chemotherapy Protocols - administration & dosage

Antineoplastic Combined Chemotherapy Protocols - adverse effects

Bradycardia - chemically induced

Bradycardia - diagnosis

Bradycardia - drug therapy

Cardiotonic Agents - therapeutic use

Dopamine - therapeutic use

Electrocardiography, Ambulatory

Humans

Imidazoles - administration & dosage

Male

Melanoma - drug therapy

Middle Aged

Oximes - administration & dosage

Protein Kinase Inhibitors - administration & dosage

Protein Kinase Inhibitors - adverse effects

Pyridones - administration & dosage

Pyridones - adverse effects

Pyrimidinones - administration & dosage

Pyrimidinones - adverse effects

Skin Neoplasms - drug therapy

Treatment Outcome

1 Record Views

Title: Trametinib-Associated Bradycardia
Creators - without role: Luai Alhazmi - University of Toledo
Mohammad M Karim - Division of Cardiovascular Medicine, New York Medical Center, Valhalla, NY
Mohammad Al-Sarie - University of Toledo
Roland Skeel - University of Toledo
Saima Karim - University of Toledo
Publication Details: American journal of therapeutics, Vol.26(5), pp.e657-e659
Identifiers: 9917188108331
Academic Unit: Jazan University
Language: English
Resource Type: Journal article